Bone scintigraphy predicts the risk of spinal cord compression in hormone-refractory prostate cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 7, 2004, Pages 958-963

  Soerdjbalie Maikoe, Vidija ^a   Pelger, Rob C M ^a   Lycklama À Nijeholt, Guus A B ^a   Arndt, Jan Willem ^a   Zwinderman, Aeilko H ^a   Bril, Herman ^b   Papapoulos, Socrates E ^a   Hamdy, Neveen A T ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

Bone scintigraphy; Metastatic prostate cancer; PSA; Spinal cord compression; Tumour stage

Indexed keywords

ALKALINE PHOSPHATASE; ANTIANDROGEN; GOSERELIN; MEDRONATE TECHNETIUM TC 99M; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE SCINTISCANNING; CANCER GRADING; CLINICAL TRIAL; ENZYME ACTIVITY; HORMONE REFRACTORY PROSTATE CANCER; HORMONE RESISTANCE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSTATE CANCER; SCORING SYSTEM; SOLOWAY GRADING; SPINAL CORD COMPRESSION; TECHNIQUE; TUMOR VOLUME; VERTEBRA;

EID: 3142677838     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1479-z     Document Type: Article

References (39)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics 1996. CA Cancer J Clin 1996; 46:5-27.
2. McKillop JH. Bone scanning in metastatic disease. In Fogelman I, ed. Bone scanning in clinical practice. Berlin Heidelberg New York: Springer; 1987:41-60.
3. Jacobs SC. Spread of prostatic cancer to bone. Urology 1983; 21:337-344.
4. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumor; diagnosis and treatment. Ann Neurol 1978; 3:40-51.
5. Soerdjbalie-Maikoe V, Pelger RCM, Lycklama à Nijeholt AAB, Arndt JW, Zwinderman AH, Papapoulos SE, Hamdy NAT. Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton. Eur J Nucl Med Mol Imaging 2002; 29:494-498.
6. Osborn JL, Getzenberg RH, Trump DL. Spinal cord compression in prostate cancer. J Neurooncol 1995; 23:135-147.
7. Flynn DF, Shipley WU. Management of spinal cord compression secondary to metastatic prostatic carcinoma. Urol Clin North Am 1991; 18:145-152.
8. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rev 1966; 50:125-128.
9. Gleason D, Mellinger G and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111:58-64.
10. Gleason DF. Histologic grading of prostate cancer: a perspective. Hum Pathol 1992; 23:273-297.
11. Soloway MS, Hardeman SW, Hickey D, Raymond J, Todd B, Soloway S, Moinuddin M. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988; 61:195-202.
12. Silverberg E, Lubera J. Cancer statistics. CA Cancer J Clin 1987; 37:2-19.
13. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma. Analysis of 1000 autopsy cases. Cancer 1950; 2:74-85.
14. Franks LM. The spread of prostatic carcinoma. J Pathol Bacteriol 1956; 72:603-611.
15. Abrams HL. Skeletal metastases in carcinoma. Radiology 1950; 55:534-538.
16. Turner JW, Jaffe HL. Metastatic neoplasms. A clinical and roentgenological study of involvement of skeleton and lungs. Am J Roentgenol 1940; 43:479-492.
17. Elkin M, Mueller HP. Metastases from cancer of the prostate. Cancer 1954; 7:1246-1248.
18. Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult and the impostors. Spine 1990; 15:1-4.
19. Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol 1991; 9:509-524.
20. Miller F, Whitehill R. Carcinoma of the breast metastatic to the skeleton. Clin Orthop 1984; 184:121-127.
21. Krishnamurthy GT, Tubis M, Hiss J, et al. Distribution pattern of metastatic bone disease. A need for total body skeletal image. JAMA 1977; 237:2504-2506.
22. Byrne TN. Spinal cord compression from epidural metastases. N Engl J Med 1992; 327:614-619.
23. Berrettoni BA, Carter JR. Mechanisms of cancer metastasis to bone. J Bone Joint Surg Am 1986; 68:308-312.
24. Willems A. Secondary tumours of bones. In: The spread of tumours in the human body, 3rd edn. London: Butterworth; 1973:229-250.
25. Paulson DF and the Uro-Oncology Research Group. The impact of current staging procedures in assessing disease extent in prostatic adenocarcinoma. J Urol 1979; 121:300-302.
26. Biersack HJ, Wegner G, Distelmaier W. Bone metastases of prostate cancer in relation to tumour size and grade of malignancy. Nuklearmedizin 1980; 19:29-32.
27. Shih WJ, Mitchell B, Wierzbinski B. Prediction of radionuclide bone imaging findings by Gleason histologic grading of prostate carcinoma. Clin Nucl Med 1991; 16:763-766.
28. Chybowski FM, Keller JJL, Bergstrahl EJ. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol 1991; 145:313-318.
29. Barron KD, Hirano A, Araki S, Terry RD. Experiences with metastatic neoplasms involving the spinal cord. Neurology 1959; 9:91.
30. Bruckman JE, Bloomer WD. Management of spinal cord compression. Semin Oncol 1978; 5:135-140.
31. Gilbert RW, Kim JH, Posner JB. Epidural spinal cord compression from metastatic tumors: diagnosis and treatment. Ann Neurol 1978; 3:40-51.
32. Ruff RL, Lanska DJ. Epidural metastases in prospectively evaluated veterans with cancer and back pain. Cancer 1989; 63:2234-2241
33. McGregor B, Tulloch AG, Quinlan MF, et al. The role of bone scanning in the assessment of prostatic carcinoma. Br J Urol 1978; 50:178-181.
34. O' Donoghue EP, Constable AR, Sherwood T, et al. Bone scanning and plasma phosphatases in carcinoma of the prostate. Br J Urol 1978; 50:172-177.
35. Buck AC, Chisholm GD, Merrick MV, et al. Serial fluorine- 18 bone scans in the follow up of carcinoma of the prostate. Br J Urol 1975; 47:287-294.
36. Merrick MV, Stone AR, Chisholm GD. Prostatic cancer. Nuclear medicine. Recent Results Cancer Res 1981; 78:108-118.
37. Pollen JJ, Gerber K, Ashburn WL, et al. The value of nuclear bone imaging in advanced prostatic cancer. J Urol 1981; 125:222-223.
38. Edelstyn GA, Gillespie PJ, Grebbel FS. The radiological demonstration of osseous metastases: experimental observations. Clin Radiol 1967; 18:158-162.
39. Coleman RE, Rubens RD, Fogelman I. Reappraisal of the baseline bone scan in breast cancer. J Nucl Med 1988; 29:1045-1049.